Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is a global medical technology company specializing in structural heart disease and critical care monitoring. Through its subsidiaries, particularly Edwards Lifesciences LLC, the company provides a range of cardiovascular devices and services to the U.S. federal government, primarily the Department of Veterans Affairs (VA) and Veterans Health Administration (VHA). These products include transcatheter heart valves, surgical implants, prosthetics, and hemodynamic monitoring systems. As a leader in patient-focused innovations for structural heart disease and critical care monitoring, Edwards Lifesciences leverages its expertise to support healthcare services for veterans and active military personnel.

The majority of Edwards Lifesciences' federal contract awards are for the supply of specialized cardiovascular devices to VA medical centers across various Veterans Integrated Service Networks (VISNs). Key products provided include Sapien transcatheter aortic valves, Inspiris Resilia aortic valves, and other surgical implants for heart valve replacements. The company also delivers prosthetics, aortic conduits, and transcatheter aortic valve replacement (TAVR) kits. In addition to medical devices, Edwards Lifesciences provides services such as maintenance and software upgrades for its Hemosphere critical care monitors. The primary funding agency is the VA, with some contracts from the Defense Health Agency. Most awards are firm-fixed price purchase orders without set-aside designations, reflecting Edwards Lifesciences' position as a specialized provider in the cardiovascular medical device market.

Edwards Lifesciences Corporation holds a single Indefinite Delivery Contract (IDC) through its subsidiary, Edwards Lifesciences LLC. This IDC, awarded by the Veterans Integrated Service Network 17, is for CLEAR SIGHT SERVICE with a ceiling value of $128,000 and an ultimate completion date of September 27, 2025. The contract is a single-award vehicle with no set-aside designation. While specific task orders under this IDC are not detailed in the provided information, it likely supports the VA's efforts to provide advanced medical services to veterans, potentially relating to cardiovascular care or monitoring. This IDC demonstrates Edwards Lifesciences' ongoing relationship with the VA and its commitment to supporting veteran healthcare services beyond individual product deliveries.